Emergent Biosolutions (EBS) Misses Q2 EPS by 2c; Mixed Guidance

Article Stock Quotes (1) Comments (0)

Emergent Biosolutions (NYSE: EBS) reported Q2 EPS of $0.21, $0.02 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $70.4 million versus the consensus estimate of $76.2 million.

Emergent Biosolutions sees FY2012 revenue of $60-$70 million, versus the consensus of $78.32 million.

Emergent Biosolutions sees FY2012 revenue of $280-$300 million, versus the consensus of $292.99 million.

For earnings history and earnings-related data on Emergent Biosolutions (EBS) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
• Stage Stores, Inc. (SSI) Posts Surprise Q1 Loss of 2c/Share
• UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light

Create E-mail Alert Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?